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Leptotrichia species are normal constituents of the oral cavity and the genitourinary tract microbiota that are known to provoke
disease in immunocompromised patients and rarely in immunocompetent individuals. Following the description of Leptotrichia
goodfellowii sp. nov., two cases of endocarditis by this species have been reported. Here, we report a case of Leptotrichia goodfellowii
endocarditis in an immunocompetent patient with a valvular allograft. The isolation and identification of Leptotrichia can be
challenging, and it is likely that infection with this pathogen is significantly underdiagnosed. A definitive identification, as in this
case,most often requires 16S rRNAgene sequencing, highlighting the increasingly important role of this diagnosticmodality among
immunocompetent patients with undetermined anaerobic bacteremia.
1. Introduction
Leptotrichia species are normal constituents of the oral
cavity [1], intestinal tract [2], and genitourinary tract [3]
that produce lactic acid as a major metabolic end product
[4]. Although part of the resident microbiota, Leptotrichia
species can spread from primary colonization sites and are
known to cause infections in humans [5]. Outside of the
oral cavity, they have been associated with aortic aneurysms
[6] and hepatic abscesses [7] and are known to cause
bacteremia in immunocompromised hosts [8]. However,
they are rarely recovered from the blood of patients who
are not immunocompromised; the few reported cases of
infection in apparently immunocompetent hosts were cases
of endocarditis in patients with preexisting cardiac valvular
lesions [9–11]. Here, we report the third definitive case
of L. goodfellowii endocarditis in an immunocompetent
patient with a cardiac lesion, identified by 16S rRNA gene
sequencing.
2. Case Report
A 44-year-old male with a history notable for a bicuspid
aortic valve that was repaired 19 years ago via a Ross
procedure (pulmonary autograft replacement of the aortic
valve and cadaveric allograft replacement of the pulmonary
valve) was admitted for evaluation of 2-3months of persistent
daily fevers up to 39.4∘C, headaches, night sweats, and
marked fatigue of unknown origin. Review of systems was
remarkable for a week of mild painless hematochezia. He
was using aspirin frequently for control of his fevers. His
family and social history were unremarkable beyond owning
a pet dog. He reported a dental cleaning approximately 5
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months prior to presentation. At the time of presentation,
he had undergone extensive infectious and rheumatologic
evaluations for persistent but undifferentiated fevers. Blood
cultures obtained three months prior to admission, and again
one week prior to admission at a separate facility in Bactec
Plus aerobic and anaerobic FANbottles, processed in a Bactec
9120 system (BectonDickinson), were negative after 5 days of
incubation.
On physical examination the patient was febrile to 38.8∘C.
He was diaphoretic but otherwise well appearing. He had
no evidence of dental or periodontal disease and no visible
oropharyngeal abnormalities. Cardiovascular examination
was notable for an old III/VI holosystolic murmur greatest
at the left lower sternal border, radiating to the back, and an
old II/VI diastolic murmur best appreciated over the RUSB.
The pulmonary exam was unremarkable. Abdominal exam
was notable for slight tenderness to palpation in the RLQ. On
rectal exam, no perianal lesions were noted and there were
no masses in the rectal vault; he had brown, guaiac positive
stools but no melena. No other findings of endocarditis were
appreciated.
Laboratory evaluation revealed a hematocrit that was
decreased to 30.7% from a preillness baseline of 48%, an ery-
throcyte sedimentation rate (ESR) of 44mm/hr, C-reactive
protein (CRP) of 55mg/L, and creatinine of 1.01mg/dL. His
white blood cell count was 6,000 per mcL. A urinalysis
with sediment was notable for 1+ blood, and 2 red blood
cells per high-powered field on microscopy. Transthoracic
and transesophageal echocardiography revealed mild, diffuse
thickening of the mitral valve with trace mitral regurgitation
and focal thickening of the pulmonic valve homograft, which
were highly suggestive of a valvular vegetation. There was
stable, severe dilation of the aortic root. These findings were
confirmed with cardiac magnetic resonance imaging.
Blood cultures were sent on the day of admission and
processedwith theBacT/ALERT system (bioMerieux) and on
day 2 grew thin, tapered Gram-variable rods from an anaero-
bic FAN bottle. Subcultures grew only on Brucella agar plates
incubated within an anaerobic chamber, and Gram stain of
the culture revealed thin Gram-negative rods with tapered
ends. This isolate was negative for oxidase and spot indole
testing. The patient was started on vancomycin, ceftriaxone,
and metronidazole for empiric coverage. Multiple blood
cultures continued to be positive for Gram-negative rods
from anaerobic FAN bottles, and Gram-variable rods were
also subsequently isolated from both aerobic and anaerobic
FAN bottles over the following 2 days during which the
patient was taking antibiotics. Despite the positive blood
cultures, the patient defervesced and felt better following the
administration of antibiotics. Blood cultures drawn on day 3
of antibiotic treatment were negative and remained negative
after 5 days. At discharge, the isolate was still not identified.
Additional work-up with gas-liquid chromatography
revealed a large peak for lactic acid and a small peak for
acetic acid. The appearance on Gram stain, aerotolerance
noted on further passage, and lactic acid production were
most consistent with Leptotrichia species. A RapID ANAII
test, which uses conventional and chromogenic substrates for
species identification, did not reveal any satisfactory matches.
Isolates were sent for 16S rRNA sequencing as a defini-
tive diagnosis was unattainable via conventional phenotypic
methods. Following 16S rRNA sequencing, a search of the
Isentio RipSeq 16S database yielded a match with a 99.9%
identity for L. goodfellowii and 7.3% difference separating it
from another related species.
The patient was discharged on piperacillin/tazobactam
and metronidazole as these antibiotics had demonstrated
clinical effectiveness in a previous case report [9]. Antibi-
otic susceptibility testing of the isolates via Etest showed
sensitivity to ceftriaxone (MIC 0.016𝜇g/mL), clindamycin
(MIC 0.016𝜇g/mL), metronidazole (MIC 0.25𝜇g/mL), and
penicillin (MIC 0.125𝜇g/mL). Following the availability of
susceptibility data, the patient was switched to ceftriaxone
and metronidazole and in total completed a 6-week course
of antibiotics. He was then started on chronic suppressive
therapy with penicillin V potassium, which was complicated
by elevated liver transaminases and discontinued. He was
then started on cefpodoxime, which he has tolerated well.
Cardiac surgery was under consideration but ultimately
deferred as he has been otherwise asymptomatic and with
stable cardiac imaging since his hospitalization.
3. Discussion
We present an uncommon case of endocarditis with Lep-
totrichia goodfellowii in an immunocompetent patient with
a history of a Ross procedure. Our patient met 1 major
and 2 minor Duke criteria for possible infective endocarditis
(positive blood cultures, fever, and predisposing condition).
A diagnosis of infective endocarditis was further supported
by his chronic night sweats, fevers, and elevated inflammatory
markers (ESR and CRP). Given the likelihood of infective
endocarditis, and his predisposing cardiac risk factors, hewas
promptly started on antibiotic treatment following identifica-
tion of positive blood cultures.
Leptotrichia are a rare cause of human infections, with
only 54 cases described in the literature as of 2008 [5]. Given
the difficulty in isolating and identifying these organisms
using currently available methods, it is possible that their
role in human disease is underestimated. A 62-month ret-
rospective survey of 4,857 episodes of anaerobic bacteremia
identified Leptotrichia spp. as the causative pathogen in 7.3%
of cases [12]. With the advent of improved diagnostics and
sequencing technology, it is possible that their designation as
emerging pathogens in human disease will likely be further
elucidated. The first two documented cases of L. goodfellowii
infection were isolated from blood cultures of patients with
endocarditis [9]. Subsequently, this species was isolated from
blood cultures obtained from a stillborn thought to have
expired secondary to fetal bacteremia [13], wound cultures
from a patient with a wound infection following a dog bite,
and most recently from an immunocompetent patient with
bacteremia [14], suggesting that this organism has broader
infectious potential than previously appreciated [15].
The association between Leptotrichia species and endo-
carditis is rare. Our case accounts for the fifth reported case
of Leptotrichia species endocarditis (Table 1). Three of these
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cases were definitively identified as Leptotrichia goodfellowii
[9], and another was due to a Leptotrichia buccalis-like organ-
ism [10] that was likely L. goodfellowii, possibly suggesting a
link between this particular species and endocarditis. Addi-
tionally, whereas the majority of infections with Leptotrichia
sp. have been documented in immunocompromised hosts,
none of the cases of endocarditis occurred in immuno-
compromised patients, suggesting that preexisting cardiac
lesions are on their own risk factors for developing infection
with this organism. Infection in our patient presented in a
subacute fashion, unlike three of the four previously reported
cases, which had more fulminant courses. Leptotrichia sp.
are predominantly susceptible to beta-lactam antibiotics,
carbapenems, clindamycin, chloramphenicol, tetracyclines,
and metronidazole but resistant to vancomycin and amino-
glycosides [2]. Our patient successfully completed a 6-week
course of targeted antibiotic therapy following definitive
identification, which was followed by chronic suppressive
therapy.
Leptotrichia species are difficult to isolate and identify
[16]. Itmay take several days for a culture to grow. If isolated, it
can be difficult to distinguish from closely related organisms
such as Fusobacterium, Capnocytophaga, and Lactobacillus.
They produce lactic acid as a major metabolic end product,
differentiating them from other filamentous bacteria such as
Fusobacterium andBacteroides [5].They are normally straight
or curved, non-spore forming, nonmotile rods with one or
both ends pointed or rounded [17]; they often demonstrate
variability in their appearance on Gram staining. Although
they normally grow under anaerobic conditions, they can
also develop aerotolerance following repeated culture at 37∘C
in the presence of CO
2
[5]. As demonstrated in this case,
conventional phenotyping methods are seldom adequate,
making accurate diagnosis mainly dependent on molecular
methods. The causative organism in our case was predictably
difficult to isolate and identify. Notably, blood cultures when
the patient was symptomatic on two occasions prior to
admission did not grow the organism. It is unclear why
no growth was observed on multiple occasions prior to
admission, whereas all blood cultures performed at our
hospital demonstrated growth. Cultures prior to the current
admission were performed using Bactec Plus aerobic and
anaerobic FAN bottles and processed in a Bactec 9120 system
(Becton Dickinson) system, whereas cultures performed at
our hospital were processed using the BacT/ALERT sys-
tem (bioMerieux). Both FA and FAN bottles used in our
system are enriched and contain charcoal to neutralize
antibiotics and other inhibitory substances. Once isolated at
our institution, identification via conventional methods was
inconclusive and ultimately required the use of 16S rRNA
sequencing technology.
Although rare, this case should alert clinicians about the
potential pathogenicity of Leptotrichia species, as they can
cause endocarditis in patients with preexisting cardiac condi-
tions. Given the difficulty in isolation and identification, this
pathogen should also be considered in cases of blood culture
negative endocarditis, and the threshold for utilizing 16S
rRNA sequencing at the first signs of difficulty isolating and
identifying the causative organism should be low. This case
also demonstrates the utility of 16S rRNA sequencing for the
identification of difficult to identify pathogens. Decreasing
time to identification can reduce delays in implementing the
appropriate antibiotics and lead to better outcomes. Finally,
further research into the pathogenicity of this species would
allow us to better appreciate its pathogenic potential and
better identify and treat infections caused by this organism.
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